Upregulation of Synuclein-γ and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients

Table 2

The relationship between the expression of SNCG and Snai1 and the clinicopathological features of OSCC patients.

Characteristics	Cases ()	SNCG		Snai1
		Negative (%)	Positive (%)		Negative (%)	Positive (%)
Age
≤50	44	18 (40.9)	26 (59.1)	0.269	19 (43.2)	25 (56.8)	0.263
>50	50	15 (30.0)	35 (70.0)		16 (32.0)	34 (68.0)
Gender
Male	71	23 (32.4)	48 (67.6)	0.333	26 (36.6)	45 (63.4)	0.829
Female	23	10 (43.5)	13 (56.5)		9 (39.1)	14 (60.9)
T stage
T1+T2	74	23 (31.1)	51 (68.9)	0.116	32 (43.2)	42 (56.8)	0.020
T3+T4	20	10 (50.0)	10 (50.0)		3 (15.0)	17 (85.0)
Clinical stage
I+II	70	28 (40.0)	42 (60.0)	0.090	32 (45.7)	38 (54.3)	0.004
III+IV	24	5 (20.8)	19 (79.2)		3 (12.5)	21 (87.5)
Lymph node metastasis
No	60	25 (41.7)	35 (58.3)	0.077	32 (53.3)	28 (46.7)
Yes	34	8 (23.5)	26 (76.5)		3 (8.8)	31 (91.2)
Differentiation
High	45	28 (62.2)	17 (37.8)		29 (64.4)	16 (35.6)
Middle and low	49	5 (10.2)	44 (89.8)		6 (12.2)	43 (87.8)